Cogent Biosciences, Inc. COGT Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s operating lease liabilities?
- Cogent Biosciences, Inc. (COGT) reported operating lease liabilities of $14.1M in Q1 2026.
- How has Cogent Biosciences, Inc.'s operating lease liabilities changed year-over-year?
- Cogent Biosciences, Inc.'s operating lease liabilities decreased by 8.9% year-over-year, from $15.48M to $14.1M.
- What is the long-term trend for Cogent Biosciences, Inc.'s operating lease liabilities?
- Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s operating lease liabilities has grown at a 35.4% compound annual growth rate (CAGR), from $3.16M to $14.36M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.